Sagent Pharmaceuticals (SGNT) stock had a bullish inflow of $2.4 million worth of trades on uptick and an outflow of $1.08 million in downticks on Friday. The total uptick to downtick ratio stood at 2.23. The net money flow into the stock was $1.33 million. The money flow data, which is calculated as the dollar value of composite uptick minus the downtick trades indicated bullish. The block trades had a total money flow of $1.44 million. $1.44 million of block trade during Uptick was observed, which shows continued buying by the smart money on every weakness. However, Sagent Pharmaceuticals (SGNT) stock traded down $0.01 , and reached $21.66, a drop of -0.05% over the previous day. On a weekly basis, the stock is -0.64%, over the previous weeks close.
Sagent Pharmaceuticals (SGNT) : Currently there are 6 street experts covering Sagent Pharmaceuticals (SGNT) stock. The most bullish and bearish price target for the stock is $22 and $13 respectively for the short term. The average price target of all the analysts comes to $18.54. The estimated standard deviation from the target is $3.86.
Sagent Pharmaceuticals (NASDAQ:SGNT): stock turned positive on Friday. Though the stock opened at $21.7, the bulls momentum made the stock top out at $21.72 level for the day. The stock recorded a low of $21.65 and closed the trading day at $21.69, in the green by 0.09%. The total traded volume for the day was 848,178. The stock had closed at $21.67 in the previous days trading.
Sagent Pharmaceuticals, Inc. (Sagent), formerly Sagent Holding Co., is an injectable pharmaceutical company that develops and sources products that the Company sells primarily in the United States. Sagent focuses primarily on generic injectable pharmaceuticals. Sagent offers its customers a range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags. As of October 31, 2010, Sagent marketed 21 products. The Company has a 50/50 joint venture known as Sagent Strides LLC (Sagent Strides) with a subsidiary of Strides Arcolab Limited (Strides), which is an Indian manufacturer of finished pharmaceutical products.